Nonetheless, cirrhotic patients with non-characterized nodules on ultrasound, high AFP levels in the pre-treatment period, and failure to achieve SVR were important risk factors for the development of HCC during or after HCV treatment with DAAs. Here, AFP is linked to hepatocellular carcinoma.